Medical device manufacturer, Abbott, has issued a medical device safety alert concerning its Alinity ci-series System Control Module [List Number: 03R70-01; Serial Number: All; only includes Alinity ci-series System Control Modules which are configured with Alinity i Processing Modules].
The manufacturer has identified an issue with all on-market versions of Alinity ci-series software where re-use of reaction vessels (RVs) may occur after a system Stop. The issue only occurs if the system is transitioned from Processing to Stopped to Idle and has the potential to cause incorrect patient results for any Alinity i assay.
According to the manufacturer, the following specific sequence of events are required to experience the issue:
If the prior run ended with a stop while sample or reagent are in the process of being aspirated or dispensed into RVs, there could be sample/reagent in the RVs between the sample dispense and the stat diverter. Up to 4 RVs would be retained in the clean lane and could be used for future tests. If the operator does not perform step 3 (Start), the issue does not occur.
The manufacturer will be releasing Alinity ci-series Software version 2.6.2 to resolve the issue. To mitigate the issue until the software is available, operator should follow the steps below:
According to the local supplier, the affected products are distributed in Hong Kong.
If you are in possession of the affected products, please contact your supplier for necessary actions.
Posted on 19 June 2019